Parikshit Somani Banned Four Years for Doping Violation

Indian doubles specialist Parikshit Somani has been handed a four-year suspension by an independent tribunal under the International Tennis Integrity Agency (ITIA). The 26-year-old, who reached a career-high doubles ranking of No. 256, tested positive for the banned substance trimetazidine. The sample was collected during a lower-tier professional event last year in Astana, Kazakhstan, halting his competitive career immediately.

Trimetazidine is classified as a hormone and metabolic modulator, a substance strictly prohibited at all times under the tennis anti-doping program. According to the official guidelines maintained by the ITF, athletes bear ultimate responsibility for any substance found in their biological samples. The tribunal's ruling means Somani is barred from all sanctioned professional competition until September 2029, a devastating development for a player who has captured seven ITF Futures doubles titles.

Rivalry Matchup & Player Profiles

Somani's defense team argued that the positive test resulted from food contamination. However, independent scientific experts and the tribunal judges dismissed this explanation as scientifically implausible. In professional tennis, the burden of proof for contamination claims is exceptionally high, requiring rigorous documentation of food sources and metabolic timelines, which Somani's defense failed to establish.

This lengthy suspension effectively sidelines the right-handed doubles specialist during his peak athletic years. For players operating primarily on the lower tiers of the ATP Tour, a multi-year ban represents an incredibly steep uphill climb to return to active competition. Rebuilding his professional standing after 2029 will present an unprecedented physical and logistical challenge.